ACESION PHARMA ApS
Credit rating
Company information
About ACESION PHARMA ApS
ACESION PHARMA ApS (CVR number: 34083738K) is a company from FREDERIKSBERG. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -53 mDKK, while net earnings were -42.8 mDKK. The profitability of the company measured by Return on Assets (ROA) was -47.5 %, which can be considered poor and Return on Equity (ROE) was -55.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 78.8 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. ACESION PHARMA ApS's liquidity measured by quick ratio was 7.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | |||||
EBIT | -47 470.00 | -36 311.00 | -37 897.00 | -56 635.00 | -53 020.00 |
Net earnings | -42 765.00 | -31 428.00 | -25 157.00 | -46 780.00 | -42 849.00 |
Shareholders equity total | -4 704.00 | -20 048.00 | 10 344.00 | 22 983.00 | 130 799.00 |
Balance sheet total (assets) | 31 795.00 | 64 533.00 | 33 954.00 | 53 191.00 | 165 939.00 |
Net debt | -22 019.00 | -41 737.00 | -7 912.00 | -37 143.00 | - 140 400.00 |
Profitability | |||||
EBIT-% | |||||
ROA | -120.3 % | -44.6 % | -43.3 % | -124.0 % | -47.5 % |
ROE | -134.5 % | -65.3 % | -67.2 % | -280.7 % | -55.7 % |
ROI | -6235.2 % | -121.2 % | -71.1 % | -150.9 % | -52.8 % |
Economic value added (EVA) | -42 060.59 | -23 214.65 | -18 678.55 | -34 589.58 | -30 322.66 |
Solvency | |||||
Equity ratio | -12.9 % | -23.7 % | 30.5 % | 43.2 % | 78.8 % |
Gearing | -65.1 % | 157.7 % | 8.2 % | 6.7 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.9 | 1.6 | 5.7 | 4.5 | 7.8 |
Current ratio | 0.9 | 1.6 | 5.7 | 4.5 | 7.8 |
Cash and cash equivalents | 22 019.00 | 54 793.00 | 24 221.00 | 39 026.00 | 149 104.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | B | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.